Members of board, C-level, Senior/Global Vice Presidents, Directors, Heads of departments from the pharmaceutical industry involved in:
5th Annual Global Medical Affairs Summit
14 – 15 June 2023 | InterContinental Berlin
PAST SPEAKERS
SEE THE PREVIOUS SPEAKERS & CASE STUDIES





CONFERENCE TOPICS 2023
LOOK AT THE TOPICS THAT WERE DISCUSSED
- Shifting from a brand focus to a patient value focus: How to rebuild trust between pharmaceutical companies and patients?
- How to break through the performance by fostering the right culture for individuals and teams
- Improving the performance of medical affairs by implementing virtual reality
- Critical components to achieving excellence in an omnichannel approach
- Omnichannel strategy: Building trust and brand loyalty to engage healthcare professionals
- How can RWE help medical affairs professionals?
- The art of medical science liaising – Nurture the next MSL generation
Designed for
- Medical Science Liaisons (MSL)
- Medical Information
- Scientific Affairs
- Real World Evidence
- Commercial Excellence
- Market Access
- KOL/Thought Leader Relations/Engagement
- Clinical Affairs
- Medical Review
- Health Economics and Outcomes Research/HEOR
- Product Launch
- Patient Outcome
- Patient Centricity
- Digital Medical
- Scientific Engagement
- Scientific Partnerships
- Commercial Operations
- External Affairs
- Medical Affairs Operations
- Medical Strategy
- Portfolio Planning
- Launch Management
- Medical/Scientific/Patient Communications
- Medical Affairs
- MA Excellence
- Medical Education

Irina Elyubaeva
Global Medical Director Cardiology
Servier
CASE STUDY
Patients’ Perspectives in the Educational Program for Healthcare Providers
The primary goal of medical education for HCPs is to improve patients care. Medical education demands are continuously evolving, and medical affairs educational strategies need to continue to evolve to establish effective education. Patients/patients advocates can be actively involved in the education of HCPs. To move beyond the traditional “passive” involvement of patients for “clinical demonstration” patients could be involved in co-creation and execution of the educational program to ensure that patients’ perspectives and preferences are taken into decision making process. Patient involvement in the education of HCPs can improve patient-HCP interaction, can “enrich” patient-HCP partnerships in clinical settings.
- Medical educational projects co-created with patients
- Main learning how to involve patients in meaningful ways, to address education gaps to optimize patient care and impact health outcomes
- Future directions for patient involvement in the education of HCPs
CASE STUDY
Winning as One Team: The Role of Medical Affairs in X-Functional Collaborations
The transformation of Medical Affairs from a communicator to a key strategic player is very important for the success of the business. The presentation will show how Medical Affairs can contribute as a key player to achieve common strategic goals. A good example to share is the x-KAM approach to show the value of the MSL in collaboration with the sales representatives and other functions including compliance.
- Examples of successful collaboration between Medical Affairs and other departments
- Structure, set-up and outcome of x-KAM approaches
- Role of MSL to achieve common x-functional goals in a compliant way

Karin Görner
Director Medical Affairs, MS Lead HIV/IFI
Gilead Sciences

Maja Beilmann-Schramm
Global Fled Medical Excellence and HCP Exchange
Merck
CASE STUDY
What Impact Do Current Medical Affairs Trends Have on the Role of MSLs?
The rapid development of new communication channels and ways of working have brought a number of adaptations on how medical affairs works and communicates with HCPs. Some of those changes affect the role of the Medical Science Liaison directly.
- How does Omnichannel communication influences the quantity and quality of medical insights
- Do we need to include Digital Opinion Leader in our list of External Experts/KOL/KTLs?
- What is a “Digital MSL”?
CASE STUDY
The Value of Omnichannel in a Scientific Communication Strategy
This presentation aims to demonstrate the value of omnichannel in medical communications, how we can ensure the right HCP receives the correct information at the right time through the right channel, and how the pharma industry needs to evolve and adapt due to the evolving digital world.
- Digital/classical engagement
- Omnichannel in a holistic scientific communication strategy
- The future of medical affairs in the pharma industry implementing omnichannel

Ainara Luque Saavedra
Global Medical Communications
Amgen
STAY UPDATED FOR THE 2024 EDITION
Provide Us With Your Contact Details and Our Team Will Get Back to You With All the Updates Regarding the Upcoming Edition of This Event.